Robeco Institutional Asset Management B.V. bought a new position in Molina Healthcare, Inc (NYSE:MOH - Free Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 3,247 shares of the company's stock, valued at approximately $1,070,000.
Several other institutional investors have also made changes to their positions in the company. US Bancorp DE lifted its position in shares of Molina Healthcare by 22.3% in the fourth quarter. US Bancorp DE now owns 1,993 shares of the company's stock worth $580,000 after buying an additional 364 shares during the last quarter. Smartleaf Asset Management LLC lifted its stake in shares of Molina Healthcare by 123.9% in the fourth quarter. Smartleaf Asset Management LLC now owns 347 shares of the company's stock worth $100,000 after buying an additional 192 shares during the last quarter. SRS Capital Advisors Inc. boosted its holdings in shares of Molina Healthcare by 300.7% during the 4th quarter. SRS Capital Advisors Inc. now owns 593 shares of the company's stock worth $173,000 after buying an additional 445 shares during the period. Charles Schwab Investment Management Inc. grew its stake in Molina Healthcare by 2.6% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 400,080 shares of the company's stock valued at $116,443,000 after buying an additional 10,002 shares during the last quarter. Finally, Victory Capital Management Inc. raised its holdings in Molina Healthcare by 48.9% in the 4th quarter. Victory Capital Management Inc. now owns 141,184 shares of the company's stock worth $41,092,000 after acquiring an additional 46,350 shares during the period. 98.50% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
A number of equities analysts have recently commented on MOH shares. Guggenheim initiated coverage on Molina Healthcare in a research note on Wednesday, April 9th. They issued a "neutral" rating on the stock. Robert W. Baird reaffirmed a "neutral" rating and set a $375.00 price objective (up previously from $331.00) on shares of Molina Healthcare in a research report on Tuesday, April 15th. Morgan Stanley began coverage on Molina Healthcare in a research note on Monday, June 9th. They set an "overweight" rating and a $364.00 price target on the stock. Mizuho boosted their price objective on Molina Healthcare from $376.00 to $400.00 and gave the company an "outperform" rating in a research report on Wednesday, April 9th. Finally, Wall Street Zen downgraded shares of Molina Healthcare from a "buy" rating to a "hold" rating in a research note on Sunday. Ten investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average target price of $364.21.
Read Our Latest Analysis on Molina Healthcare
Molina Healthcare Price Performance
Molina Healthcare stock traded up $0.51 during trading hours on Thursday, hitting $239.51. 788,916 shares of the stock were exchanged, compared to its average volume of 704,136. The stock has a market capitalization of $12.98 billion, a P/E ratio of 11.56, a P/E/G ratio of 1.03 and a beta of 0.55. The business's 50-day moving average is $305.25 and its two-hundred day moving average is $306.22. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.63 and a current ratio of 1.63. Molina Healthcare, Inc has a 12 month low of $236.37 and a 12 month high of $365.23.
Molina Healthcare (NYSE:MOH - Get Free Report) last released its quarterly earnings results on Wednesday, April 23rd. The company reported $6.08 EPS for the quarter, topping analysts' consensus estimates of $5.96 by $0.12. Molina Healthcare had a return on equity of 28.38% and a net margin of 2.81%. The business had revenue of $11.15 billion for the quarter, compared to analyst estimates of $10.86 billion. During the same period in the prior year, the company earned $5.73 EPS. Molina Healthcare's revenue for the quarter was up 12.2% on a year-over-year basis. Equities research analysts expect that Molina Healthcare, Inc will post 24.4 EPS for the current fiscal year.
Insider Activity at Molina Healthcare
In other Molina Healthcare news, CEO Joseph M. Zubretsky sold 87,500 shares of the company's stock in a transaction on Wednesday, April 30th. The stock was sold at an average price of $320.06, for a total transaction of $28,005,250.00. Following the transaction, the chief executive officer owned 257,715 shares of the company's stock, valued at approximately $82,484,262.90. This represents a 25.35% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Richard M. Schapiro sold 669 shares of Molina Healthcare stock in a transaction on Tuesday, April 29th. The stock was sold at an average price of $320.50, for a total transaction of $214,414.50. Following the sale, the director directly owned 11,244 shares of the company's stock, valued at $3,603,702. This represents a 5.62% decrease in their position. The disclosure for this sale can be found here. 1.10% of the stock is owned by corporate insiders.
Molina Healthcare Company Profile
(
Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Further Reading

Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.